In the SAPiT-1 study, initiation of ART during tuberculosis treatment in patients with CD4 counts < 500 cells/μL reduced mortality by 56% compared with starting ART after tuberculosis treatment completion [32]. This evidence concerns the gene CD4 and tuberculosis.